CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION-Reference-Cited by-同舟云学术

CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

Published:1980-02 Issue:8164 Volume:315 Page:327-329
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Powles R.L.,Clink H.M.,Spence D.,Morgenstern G.,Watson J.G.,Selby P.J.,Woods M.,Barrett A.,Jameson Beryl,Sloane J.,Lawler S.D.,Kay H.E.M.,Lawson D.,McElwain T.J.,Alexander P.

Publisher

Elsevier BV

Subject

General Medicine

Reference11 articles.

1. Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts;Storb;Transplantation,1970

2. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation;Thomas;Blood,1978

3. Anti-human thymocyte globulin (ATG) for prophylaxis and treatment of graft versus host disease in recipients of allogeneic marrow grafts;Weiden;Transplant Proc,1978

4. Marrow transplantation for acute non-lymphoblastic leukemia in first remission;Thomas;N Engl J Med,1979

5. Biological effects of cyclosporin A: a new antilymphocytic agent;Borel;Ag Actions,1976

Cited by 291 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and implementation of evidence-based, nurse-leading early warning model and healthcare quality improvement project for transplant-associated thrombotic microangiopathy: a mixed-methods, before-and-after study;BMC Nursing;2024-08-07

2. The transplant rejection response involves neutrophil and macrophage adhesion-mediated trogocytosis and is regulated by NFATc3;Cell Death & Disease;2024-01-19

3. Graft-Versus-Host Disease;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

4. Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation;Cancers;2023-01-22

5. An Overview of Graft-Versus-Host Disease;Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation;2023